ALEXANDRIA, Va., March 17 -- United States Patent no. 12,576,044, issued on March 17.
"Treatment of Alzheimer's disease" was invented by Paul A. Knepper (Chicago).
According to the abstract* released by the U.S. Patent & Trademark Office: "Neurodegenerative diseases are treated by the co-administration to a subject of an effective amount of a stilbene, a flavonol, and a TLR4/MD2 receptor antagonist. A preferred stilbene is resveratrol, a preferred flavonol is quercetin, and a preferred TLR4/MD2 receptor antagonist is curcumin."
The patent was filed on May 3, 2023, under Application No. 18/143,001.
*For further information, including images, charts and tables, please visit: http://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOF...